Triple-negative breast cancer (TNBC) is a distinct subgroup of breast cancer that does not express estrogen receptor (ER)
progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) with a poor prognosis and an increased risk of relapse after surgery. The imaging modalities for diagnosing TNBC and their research progress were reviewed in this paper.